SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 414 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $9,465 | +74.1% | 65 | +54.8% | 0.00% | – |
| Q1 2024 | $5,438 | -37.3% | 42 | -53.3% | 0.00% | – |
| Q4 2023 | $8,679 | -11.6% | 90 | +11.1% | 0.00% | – |
| Q3 2023 | $9,819 | +138.2% | 81 | +125.0% | 0.00% | – |
| Q2 2023 | $4,123 | -32.0% | 36 | -18.2% | 0.00% | – |
| Q1 2023 | $6,065 | +73.3% | 44 | +63.0% | 0.00% | – |
| Q4 2022 | $3,499 | +16.6% | 27 | -10.0% | 0.00% | – |
| Q3 2022 | $3,000 | – | 30 | +400.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 6 | -96.5% | 0.00% | – |
| Q1 2022 | $13,000 | -78.0% | 171 | -73.0% | 0.00% | -100.0% |
| Q3 2021 | $59,000 | +51.3% | 634 | +27.1% | 0.00% | 0.0% |
| Q2 2021 | $39,000 | -25.0% | 499 | -28.6% | 0.00% | 0.0% |
| Q1 2021 | $52,000 | -56.3% | 699 | 0.0% | 0.00% | -66.7% |
| Q4 2020 | $119,000 | +21.4% | 699 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $98,000 | -12.5% | 699 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $112,000 | +64.7% | 699 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $68,000 | -24.4% | 699 | 0.0% | 0.00% | -33.3% |
| Q4 2019 | $90,000 | +69.8% | 699 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $53,000 | -50.0% | 699 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $106,000 | +27.7% | 699 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $83,000 | +9.2% | 699 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $76,000 | -32.7% | 699 | 0.0% | 0.00% | -20.0% |
| Q3 2018 | $113,000 | +22.8% | 699 | 0.0% | 0.01% | +25.0% |
| Q2 2018 | $92,000 | +76.9% | 699 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $52,000 | +33.3% | 699 | 0.0% | 0.00% | +33.3% |
| Q4 2017 | $39,000 | +21.9% | 699 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $32,000 | +146.2% | 699 | +75.2% | 0.00% | +200.0% |
| Q2 2017 | $13,000 | +8.3% | 399 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $12,000 | +9.1% | 399 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $11,000 | -56.0% | 399 | 0.0% | 0.00% | -66.7% |
| Q3 2016 | $25,000 | +212.5% | 399 | 0.0% | 0.00% | +200.0% |
| Q2 2016 | $8,000 | 0.0% | 399 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $8,000 | -46.7% | 399 | 0.0% | 0.00% | -66.7% |
| Q4 2015 | $15,000 | +15.4% | 399 | 0.0% | 0.00% | -40.0% |
| Q3 2015 | $13,000 | +8.3% | 399 | 0.0% | 0.01% | +25.0% |
| Q2 2015 | $12,000 | +140.0% | 399 | 0.0% | 0.00% | +100.0% |
| Q1 2015 | $5,000 | – | 399 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
| Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
| Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
| TOBAM | 371,107 | $27,659,000 | 1.18% |
| Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
| Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
| FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
| Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
| Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |